ArticleApplied health economics and health policy2013

A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use.

David Price et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.